Recombinant immunotoxins
- PMID: 8825117
- DOI: 10.1007/BF01803778
Recombinant immunotoxins
Abstract
Pseudomonas exotoxin has been genetically modified so that it targets cancer cells. This was accomplished by deleting its cell binding domain and replacing it with Fv fragments of antibodies that react with breast, colon, and other cancers. Several recombinant immunotoxins are now in clinical trials.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical